Skip to main content

Drew Schardt

Aug 12, 2025

12:24
So how would you like to address that?
12:26
Yeah, listen, I think you're absolutely right.
12:28
And that CEO is right in that being private, it had this stigma that, oh, there's no oversight or is so risky.
12:37
That's absolutely not the case.
12:38
And again, when you're talking about what I'm kind of putting most of this discussion around companies of size and scale that are mature, 100 million plus of revenue, a quote unquote buyout space.
12:48
you're subject to all the same financial agencies and regulatory bodies that most public companies are.
12:56
The difference really comes mostly around the reporting requirement.

6 MINS LATER

18:48
And if I threw out the notion of dual class shares, poison pills, what are your thoughts on those in that context?

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click “Accept All” to consent, or “Decline non-essential” to opt out of non-essential cookies. Read our Privacy Policy.